20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Regulation of cell migration and adhesion
#4802Therapeutic methods for treating vascular eye disorders with DII4 antagonists
#4803THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE
#480413-transmembrane protein expressed in prostate cancer
#4805Methods for Affecting Body Composition
#4806Expanding the eukaryotic genetic code
#4807Method of reducing cell death by administering a Sfrp polypeptide
#4808Substances for preventing and treating autoimmune diseases
#4809SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES
#4810Selectively targeted antimicrobial peptides and the use thereof
#4811Antibodies to tumor associated proteins
#4812Ophthalmic and contact lens solutions containing peptides as preservative
#4813Positive Modulator of Bone Morphogenic Protein-2
#4814Pharmaceutical compositions and methods of using secreted frizzled related protein
#4815Compositions and Methods for the Systemic Treatment of Arthritis
#4816Compositions and Methods for the Systemic Treatment of Arthritis
#4817Hsp and Supraventricular Arrhythmia
#4818Screening method for an agent for treatment of neurodegenerative disease
#4819AGENT FOR INDUCING EMBRYONIC STEM CELL TO ECTODERMAL CELL, METHOD FOR OBTAINING THE SAME, AND USE OF THE SAME
#4820Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
#4821Methods of altering bone growth by administration of sost or wise antagonist or agonist
#4822Compositions and methods for treating inflammation and auto-immune diseases
#4823Compositions and methods for the systemic treatment of arthritis
#4824METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1
#4825Interleukin-15 antagonists for the treatment of anemia
#4826DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#4827Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)
#4828Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#4829Methods of suppressing microglial activation
#4830Methods for Treating Hiv by Inhibiting Cd4 Down-Modulation
#4831Regional delivery of therapeutic agents for the treatment of vascular diseases
#4832Multi-formed collagenous biomaterial medical device
#4833Binding agents for CD44 glycoproteins and methods of use
#4834Methods of Treatment For Injured or Diseased Joints
#4835Alpha B-crystallin as a therapy for rheumatoid arthritis
#4836Methods and compositions for treating conditions involving abnormal angiogenesis
#4837Uses of neuronal pannexins for therapy and diagnosis in mammals
#4838Heat shock protein 20-related polypeptides and uses therefor
#4839Mucinous glycoprotein (MUC-1) vaccine
#4840Methods and compositions for the treatment of medical disorders
#4841Vector system
#4842Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
#4843USE OF GELSOLIN TO TREAT INFECTIONS
#4844METHODS FOR TREATMENT OF INFLAMMATORY DISEASE AND CHLAMYDIA INFECTIOUS DISEASE
#4845Activation and inhibition of the immune system
#4846Bead based receptor biology
#4847USE OF GELSOLIN TO TREAT INFECTIONS
#4848Neutralizing antibodies and methods of use thereof
#4849Measurement of GGA proteins for diagnosing BACE associated disease
#4850TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS
#4851Methods of modulating angiogenesis
#4852Compositions and methods for treating STAT-6 associated diseases or conditions
#4853Uses Of Galectin-2
#4854Use of an agent that restores tissue perfusion and oxygenation
#4855Method for treating chronic pain
#4856HDL for the treatment of stroke and other ischemic conditions
#4857Food Composition For Rapidly Attenuating Inflammatory Responses
#4858Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#4859Use of a Dg147 Protein Product for Preventing and Treating Metabolic Disorders
#4860Use of an agent that restores tissue perfusion and oxygenation
#4861Apoptin-associating protein
#4862Method for detecting candidate alzheimer's disease drug
#4863PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#4864Method for promoting hard tissue formation
#4865Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton
#4866Methods for treating cancers and restenosis with P21
#4867Composition and methods for promoting wound healing and tissue regeneration
#4868Composition for Treating Virus Infection Disease Comprising Jab1
#4869Modulation of Muc1 Mediated Signal Transduction
#4870Preventive or therapeutic agents for diseases including interleukin-18 inhibitor as an active ingredient
#4871Methods and compositions for modulating the immune system and uses thereof
#4872EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders
#4873Immobilized biologically active entities having a high degree of biological activity
#4874Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
#4875Use of recombinant heat shock protein complexed to kidney cancer antigen
#4876Antibodies to a paralytic peptide
#4877Paralytic Peptide For Use In Neuromuscular Therapy
#4878Administration of gene-regulatory peptides
#4879Peptides selectively lethal to malignant and transformed mammalian cells
#4880Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
#4881Attenuation of reperfusion injury
#4882Methods and compositions for treating hypercholesterolemia
#4883Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
#4884Control of function of intracellular Ca ion
#4885Compositions and methods for detecting and treating HIV infections
#4886Regulation of oncogenesis by Akt-specific isoforms
#4887Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases
#4888Apoptin-associating protein
#4889Methods of treating various cancers using melanoma differentiation associated protein-7
#4890Combination therapy for the treatment of Alzheimer's disease
#4891Stable analogs of peptide and polypeptide therapeutics
#4892TREATMENT OF INFECTIONS AND OTHER DISORDERS
#4893Pharmaceutical compositions comprising fragments and homologs of troponin subunits
#4894TRPS1-mediated modulation of hair growth
#4895Inhibiting JNK Signaling Promotes CNS Axon Regeneration
#4896Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
#4897Composition Comprising Beta-Defensin 2
#4898METHODS AND THERAPEUTICS TO FACILITATE LIVER REPAIR
#4899Paralytic Peptide For Use In Neuromuscular Therapy
#4900Polynucleotide encoding a TRIM-Cyp polypeptide, compositions thereof, and methods of using same
#4901Milk protein isolate and process for its preparation
#4902Method for Screening and Compositions for Treating Cancers
#4903Annexin V for Preventing Atherothrombosis and Plaque Rupture
#4904ARTIFICIAL NICHES FOR ENHANCEMENT OF REGENERATIVE CAPACITY OF STEM CELLS IN AGED AND PATHOLOGICAL ENVIRONMENTS
#4905Protamine-Adenoviral Vector Complexes and Methods of Use
#4906Modulating serum amyloid a interaction with tanis and agents useful for same
#4907ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES
#4908Medicament for the treatment of fungal infections particularly aspergillosis
#4909Compositions and methods for alleviating joint pain and improving joint flexibility
#4910Uses of Sperm Membrane Protein Obf
#4911Peptides with antioxidant and antimicrobial properties
#4912Peptides of Syndecan-1 For Inhibiting Angiogenesis
#4913Methods and compositions for altering mucus secretion
#4914Methods of inducing IL-10 production
#4915Methods of treating obesity using satiety factors
#4916Pharmaceutical compositions containing the long pentraxin PTX3
#4917IL-1 antagonist formulations
#4918Tumor antigen protein and use thereof
#4919Targeting of triacylglycerol synthase gene for tuberculosis treatment
#4920Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
#4921System and method for genetically treating cardiac conduction disturbances
#4922Characterization of c19orf10, a Novel Synovial Protein
#4923Retinal dystrophy-associated protein and uses thereof
#4924P277 PEPTIDE FORMULATIONS OR VARIANTS THEREOF HAVING OPTIMIZED STABILITY
#4925THERAPEUTIC AGENT FOR TUMOR OF NEURAL ORIGIN
#4926APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#4927CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
#4928Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
#4929Alpha-1-acid glycoprotein for the treatment of diabetes
#4930Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
#4931Combinatorial Methods For Inducing Cancer Cell Death
#4932METHOD FOR IMPROVING NEUROTRANSMISSION FAILURE USING A NOVEL AGENT
#4933Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#4934Genes and markers in type 2 diabetes and obesity
#4935Epas1 Gene Transfer to Improve Cell Therapy
#4936Methods and Compositions for Modulating a Steroid Receptor
#4937Composition for enhancing muscle recovery
#4938Nogo epitopic fragments for modulating immune response
#4939T1 Receptor-Like Ligand II and Uses Thereof
#4940COMPOSITIONS FOR ENHANCED EPITHELIAL PERMEATION OF PEPTIDE YY FOR TREATING OBESITY
#4941Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
#4942AVIAN FOLLISTATIN PRODUCT
#4943Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
#4944COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA
#4945Modulators of gluconeogenesis
#4946Compositions of active Wnt protein
#4947Methods and compositions for the diagnosis and treatment of cancer
#4948Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
#4949Method of treating skin ulcers with vectors encoding hepatocyte growth factor
#4950Methods and compositions for treating conditions
#4951Method of enhancing cardiac tissue repair by administering a SFRP polypeptide
#4952Methods of treating cardiac disorders
#4953Dep2 and its uses in major depressive disorder and other related disorders
#4954DEP2 and its uses in major depressive disorder and other related disorders
#4955Methods for the treatment of macular degeneration and related eye conditions
#4956Methods and compositions for treating disorders involving excitotoxicity
#4957Methods of treating diabetes
#49587,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
#4959Compositions and methods for viscosupplementation
#4960Novel medicament for treating neurodegenerative diseases
#4961Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils
#4962Use of nitric oxide adducts
#4963Method of modulating inflammatory response by downregulation of activin
#4964NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS
#4965TREATMENT OF ALZHEIMER'S DISEASE WITH INHIBITORS OF APOE BINDING TO APOE RECEPTOR
#4966Methods of decreasing vascular calcification using IL-1 inhibitors
#4967Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
#4968Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same
#4969Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
#4970METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN
#4971Methods of producing growth factor complex
#4972Genes and proteins associated with angiogenesis and uses thereof
#4973Methods for treating diseases and increasing longevity
#4974Methods of using gelsolin to treat or prevent bacterial sepsis
#4975Peptides selectively lethal to malignant and transformed mammalian cells
#4976Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
#4977Agents for Regulating Adiponectin Receptor Expression
#4978Regulators of the non-genomic action of progesterone and methods of use
#4979P62 as a diagnostic tool for alzheimer's disease
#4980Pharmaceutical combined preparation containing a therapeutic protein
#4981Method of preventing or reducing the risk or incidence of cancer
#4982Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
#4983Methods and compositions for the treatment of neurological diseases and disorders
#4984Lipid therapy
#4985DETECTION OF AUTOANTIBODIES TO CYTOKERATIN 18 PROTEIN IN PATIENTS WITH BRONCHIAL ASTHMA AND CHRONIC RHINITIS
#4986Amniotic membrane preparations and purified compositions and anti-inflammation methods
#4987Cat dander allergen treatments
#4988PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY
#4989Methods of treating muscular wasting diseases using NF-κB activation inhibitors
#4990Drug delivery means
#4991Screening Assay and Treatment
#4992Methods and compositions for treating inflammatory disorders
#4993Methods for using and identifying modulators of Delta-like 4
#4994Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
#4995Treatment of cancers of lymphocytic cells with product R
#4996Host Defense Factor X (HDFX)
#4997Trophic factor combinations for nervous system treatment
#4998MODIFIED ANNEXIN PROTEINS AND METHODS FOR THEIR USE IN ORGAN TRANSPLANTATION AND IN PREVENTION OF THROMBOSIS AND REPERFUSION INJURY
#4999Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
#5000Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
#5001Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis
#5002XAF genes and polypeptides: methods and reagents for modulating apoptosis
#5003Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano
#5004Methods for the Treatment of Macular Degeneration and Related Eye Conditions
#5005Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
#5006Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility
#5007Recombinant lubricin molecules and uses thereof
#5008Anti-HIV Agent
#5009Anti-HIV Agent
#5010Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
#5011Methods and kits using a molecular interaction between a Smurf-1 WW domain and LIM mineralization protein isoforms
#5012Recombinant p53 adenovirus methods and compositions
#5013Method of treating arthritis using lentiviral vectors in gene therapy
#5014Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products
#5015Novel antimicrobial peptides with heparin binding activity
#5016Anti-HIV Agent
#5017Glucocerebroside treatment of pulmonary or respiratory diseases or disorders
#5018Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same
#5019Polypeptide absorbable into digestive organs
#5020METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS
#5021Side population cells in cardiac repair
#5022PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#5023PREPTIN FRAGMENTS AND METHODS OF USE
#5024Methods for slowing senescence and treating and preventiing diseases associated with senescence
#5025Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins
#5026Dairy components effective for fat loss
#5027Treatment of tumor with dnazyme directed to peroxiredoxin
#5028Methods and compositions for modulating gamete adhesion
#5029Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
#5030Peptide/Lipid Complex Formation by Co-Lyphilization
#5031Expanding the eukaryotic genetic code
#5032Methods for inhibiting adipogenesis and for treating type 2 diabetes
#5033HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
#5034Drug for preventing or treating heart diseases comprising CD9 gene
#5035Method of treating multiple sclerosis
#5036Casein derived peptides and uses thereof in therapy
#5037Peptide conjugated anti-cancer prodrugs
#5038Peptide composition
#5039METHODS OF REGULATING GROWTH AND DEATH OF CANCER CELLS
#5040Expanding the eukaryotic genetic code
#5041Uses of dna binding proteins
#5042Use of eIF-5A to kill multiple myeloma cells
#5043Methods and compounds for modulating triglyceride and vldl secretion
#5044Biological agent that causes IL-6 receptor release
#5045Use of the cathelicidin LL-37 and derivatives thereof for wound healing
#5046MKK7 activation inhibitor
#5047Decoy-containing pharmaceutical compositions and method of using the same
#5048Use of insulin-like growth factor binding protein 3 (IGF-BP3) for inhibition of tumor growth
#5049Protein involved in carcinoma
#5050Assays and methods using biomarkers
#5051Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions
#5052Human autism susceptibility gene and uses thereof
#5053Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac
#5054Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
#5055Effectors of innate immunity
#5056Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
#5057GASP1: a follistatin domain containing protein
#5058Catalyst for cleaving sugar chain
#5059Insulin epitopes for the treatment of type 1 diabetes
#5060Secreted neural apoptosis inhibiting proteins
#5061Anti-inflammatory, cytoprotective factor derivable from a probiotic organism
#5062AL-2 neurotrophic factor
#5063Isolated stra6 polypeptides
#5064Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
#5065CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE
#5066Hepcidin inhibitors for regulating iron homeostasis
#5067COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS
#5068Methods and compositions for the treatment of persistent infections
#5069Conversion of apoptotic proteins
#5070Inhibitor of interaction of granzyme b with golgin-160
#5071Hox11+, CD45− cells and methods of organ regeneration using the same
#5072Methods and compositions for inhibiting cholesterol uptake
#5073Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
#5074Diagnosis and treatment methods related to aging, especially of liver
#5075Use of NF-B inhibition in combination therapy for cancer
#5076Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity
#5077Method for preventing and treating diabetes using dg119
#5078Treatment with immunoregulatory t cells
#5079Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
#5080Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#5081Compositions of active Wnt protein
#5082Use of NF-κB inhibition in combination therapy for cancer
#5083Genetic modification of liver cells to enhance metabolic and physiological efficacy
#5084Targeted biocides
#5085Methods and compositions for the prevention and regression of neovascularization
#5086Methods for the Elimination of Pathogens and Other Particulate Agents
#5087Antibodies against a peptide epitope of apolipoprotein B
#5088Medicament comprising inhibitors of long pentraxin ptx3
#5089Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#5090Methods for treating and preventing diabetic retinopathy
#5091Methods and Compositions for Inhibiting C-MET Dimerization and Activation
#5092Truncated CMV promoters and vectors containing same
#5093Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes
#5094USES OF HUMAN ZVEN ANTAGONISTS
#5095Proton-sensing g-protein coupled receptors and dna sequences thereof
#5096Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof
#5097Use of C-reactive protein to treat immune complex-mediated renal disease
#5098Wound healing and treatment of fibrosis
#5099Methods to treat T-cell disorders using TISF
#5100Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence